|
ACAT2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.84785520218611E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.93858295871996E-13 |
| Normal-vs-Stage2 |
1.52350000004464E-06 |
| Normal-vs-Stage3 |
5.09919884095211E-11 |
| Normal-vs-Stage4 |
8.05999999999862E-05 |
| Stage1-vs-Stage2 |
9.389200E-01 |
| Stage1-vs-Stage3 |
8.100200E-01 |
| Stage1-vs-Stage4 |
6.094800E-01 |
| Stage2-vs-Stage3 |
9.310400E-01 |
| Stage2-vs-Stage4 |
6.528000E-01 |
| Stage3-vs-Stage4 |
5.402400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.68265401612189E-12 |
| Normal-vs-AfricanAmerican |
3.571900E-04 |
| Normal-vs-Asian |
1.881960E-03 |
| Caucasian-vs-AfricanAmerican |
1.854160E-01 |
| Caucasian-vs-Asian |
4.605800E-02 |
| AfricanAmerican-vs-Asian |
8.602200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.38320022102789E-10 |
| Normal-vs-Female |
1.92657001463203E-12 |
| Male-vs-Female |
7.987200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.61279878341247E-11 |
| Normal-vs-Age(41-60Yrs) |
9.17044218340379E-14 |
| Normal-vs-Age(61-80Yrs) |
7.43179962015006E-10 |
| Normal-vs-Age(81-100Yrs) |
4.021000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.108800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.039200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.694030E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.660000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.198400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.753760E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.496200E-01 |
| Classical-VS-Follicular |
2.677400E-03 |
| Classical-VS-Other |
7.487000E-01 |
| Classical-VS-Normal |
3.85129705904319E-11 |
| Tall-VS-Follicular |
5.426100E-02 |
| Tall-VS-Other |
6.930200E-01 |
| Tall-VS-Normal |
1.64989999995591E-06 |
| Follicular-VS-Other |
1.482190E-01 |
| Follicular-VS-Normal |
1.62703184258817E-12 |
| Other-VS-Normal |
1.335510E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.37778677355982E-13 |
| Normal-vs-N1 |
3.6087000054863E-08 |
| N0-vs-N1 |
5.715000E-01 |
|
|
